NT-proBNP has been shown to predict short-term and long-term mortality in patients with pneumonia.13–15 Critically ill patients with pneumonia have elevated NT-proBNP concentration in the intensive care unit setting.14 Hence, NT-proBNP can be used for the risk-stratification purpose in patients without chronic heart failure. Here, NPPB is linked to pneumonia.